CXCL12 and atherosclerosis: On the basis of the results of our experiments that the MAPK6/CXCL12 axis in the endothelium may have little effect on blood lipids and contribute to atherosclerosis largely by promoting inflammation, whereas MAPK6 in the endothelium may affect triglyceride metabolism through other pathways, which may require further exploration in the future.